These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Positron emission tomography of the heart]. Henze E Z Kardiol; 1987 May; 76(5):255-8. PubMed ID: 3497494 [TBL] [Abstract][Full Text] [Related]
24. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography. Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894 [TBL] [Abstract][Full Text] [Related]
26. [Myocardial positron computed tomography using N-13 ammonia for evaluating coronary artery disease: comparison with thallium-201 emission computed tomography]. Tamaki N; Yonekura Y; Kodama S; Senda M; Saji H; Torizuka K; Kambara H; Kawai C; Konishi Y; Ban T J Cardiogr; 1985 Sep; 15(3):553-65. PubMed ID: 3879760 [TBL] [Abstract][Full Text] [Related]
27. Impact of anatomical and functional severity of coronary atherosclerotic plaques on the transmural perfusion gradient: a [15O]H2O PET study. Danad I; Raijmakers PG; Harms HJ; Heymans MW; van Royen N; Lubberink M; Boellaard R; van Rossum AC; Lammertsma AA; Knaapen P Eur Heart J; 2014 Aug; 35(31):2094-105. PubMed ID: 24780500 [TBL] [Abstract][Full Text] [Related]
28. Positron emission tomography myocardial perfusion imaging in children with suspected coronary abnormalities. Singh TP; Muzik O; Forbes TF; Di Carli MF Pediatr Cardiol; 2003; 24(2):138-44. PubMed ID: 12360390 [TBL] [Abstract][Full Text] [Related]
30. Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography. Karamitsos TD; Leccisotti L; Arnold JR; Recio-Mayoral A; Bhamra-Ariza P; Howells RK; Searle N; Robson MD; Rimoldi OE; Camici PG; Neubauer S; Selvanayagam JB Circ Cardiovasc Imaging; 2010 Jan; 3(1):32-40. PubMed ID: 19920032 [TBL] [Abstract][Full Text] [Related]
31. [Positron emission tomography: principles and uses in cardiology]. Porenta G; Czernin J; Schelbert H Wien Med Wochenschr; 1992; 142(15-16):358-66. PubMed ID: 1481541 [TBL] [Abstract][Full Text] [Related]
32. Noninvasive assessment of myocardial perfusion and metabolism: feasibility of registering gated MR and PET images. Sinha S; Sinha U; Czernin J; Porenta G; Schelbert HR AJR Am J Roentgenol; 1995 Feb; 164(2):301-7. PubMed ID: 7839959 [TBL] [Abstract][Full Text] [Related]
33. [Hibernating myocardium and the 'no reflow' phenomenon: a study of absolute regional myocardial perfusion and glucose metabolism using positron emission tomography in chronic and acute heart disorders]. Maes A; Nuyts J Verh K Acad Geneeskd Belg; 1997; 59(3):133-60. PubMed ID: 9490915 [TBL] [Abstract][Full Text] [Related]
34. Coronary flow reserve estimated by positron emission tomography to diagnose significant coronary artery disease and predict cardiac events. Naya M; Tamaki N; Tsutsui H Circ J; 2015; 79(1):15-23. PubMed ID: 25744627 [TBL] [Abstract][Full Text] [Related]
35. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439 [TBL] [Abstract][Full Text] [Related]
36. Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction. Mariani MA; Palagi C; Donatelli F; Mengozzi G; Biadi O; Vanoli G; Landoni C; Paolini G; Lucignani G; Fazio F Am J Card Imaging; 1995 Jan; 9(1):1-8. PubMed ID: 7894227 [TBL] [Abstract][Full Text] [Related]
37. The value of quantitative myocardial perfusion imaging with positron emission tomography in coronary artery disease. Wijns W; Camici PG Herz; 1997 Apr; 22(2):87-95. PubMed ID: 9134442 [TBL] [Abstract][Full Text] [Related]
38. Economic analysis of clinical positron emission tomography of the heart with rubidium-82. Gould KL; Goldstein RA; Mullani NA J Nucl Med; 1989 May; 30(5):707-17. PubMed ID: 2785587 [TBL] [Abstract][Full Text] [Related]
39. Whole heart distribution of myocardial perfusion, metabolism and myocardial viability by positron emission tomography. Araujo LI; Maseri A Br Med Bull; 1989 Oct; 45(4):922-32. PubMed ID: 2695219 [TBL] [Abstract][Full Text] [Related]
40. Comparison of treadmill exercise versus dipyridamole stress with myocardial perfusion imaging using rubidium-82 positron emission tomography. Chow BJ; Ananthasubramaniam K; dekemp RA; Dalipaj MM; Beanlands RS; Ruddy TD J Am Coll Cardiol; 2005 Apr; 45(8):1227-34. PubMed ID: 15837254 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]